Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20211013052756N1
IRCT20211013052756N1
Completed
Phase 3

Comparison of vaginal misoprostol with and without vaginal estrogen in cervical ripening before operative hysteroscopy in postmenopausal women

Iran University of Medical Sciences0 sites102 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Iran University of Medical Sciences
Enrollment
102
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Postmenopausal women (at least more than 1 year after the last menstrual cycle)
  • •Candidates for hysteroscopy
  • •Patients must have a normal mammogram and Pap smear within the last 2 years

Exclusion Criteria

  • •Recent or current pelvic infection
  • •History of cervical conization
  • •Previous surgery on the cervix
  • •hypersensitivity to prostaglandins
  • •History of venous thrombosis
  • •Cardiovascular disease
  • •Cervical or breast malignancies
  • •Mullerian anomaly
  • •Cervical anomalies

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Comparison of the effect of vaginal misoprostol and evening primrose oil capsules with misoprostol alone on the consequences of abortion in women with intrauterine fetal deaththe consequences of abortion in women with intrauterine fetal death.Medical abortion : complete or unspecified, without complicationO04.9
IRCT20181207041873N3Iran University of Medical Sciences84
Completed
Not Applicable
A comparison of vaginal misoprostol versus vaginal misoprostol and nitric oxide donor for termination of pregnancy at 13 to 29 weeks. A prospective randomised trial
ISRCTN44341343Farhat Hached University Teaching Hospital (Tunisia)70
Completed
Phase 2
Comparison the effect of vaginal Misoprostol and vaginal Isoniazid for cervical ripening prior to hysteroscopy proceduresAbnormal uterine and vaginal bleeding, unspecified.Abnormal uterine and vaginal bleeding, unspecified
IRCT2015112821506N4Iran University of Medical Sciences100
Completed
Phase 3
A comparison of vaginal misoprostol and vaginal evening primrose oilSpontaneous abortion.Genital tract and pelvic infection following incomplete spontaneous abortionO03.0
IRCT20201218049749N1Kashan University of Medical Sciences72
Completed
Phase 2
Comparison of the Effect of Vaginal misoprostol with Oxytocin for the management pregnancy terminations with IUFD
IRCT20181218042033N2Bandare-abbas University of Medical Sciences106